Propranolol treatment of essential tremor
Richard D. Sweet, JQEL BLUMBERG, John E. Lee, Fletcher McDowell
Abstract
Richard D. Sweet, JQEL BLUMBERG, John E. Lee, Fletcher McDowell
Abstract
Propranolol treatment of patients with essential tremor, selected for chronic, nonresting tremor of hands and head causing functional impairment, benefited only one of nine patients during a double-blind study (320 mg per day). No serious cardiorespiratory complications occurred in this screened patient group, but an elderly man became agitated and depressed. We conclude that propranolol does not benefit all patients with essential tremor and that this disorder may be caused by several biochemical mechanisms.
OpenAlex reports 54 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Propranolol treatment of patients with essential tremor, selected for chronic, nonresting tremor of hands and head causing functional impairment, benefited only one of nine patients during a double-blind study (320 mg per day). No serious cardiorespiratory complications occurred in this screened patient group, but an elderly man became agitated and depressed. We conclude that propranolol does not benefit all patients with essential tremor and that this disorder may be caused by several biochemical mechanisms.
Key concepts: Propranolol, Essential tremor, Medicine, Cardiorespiratory fitness, Anesthesia, Pediatrics, Physical therapy, Physical medicine and rehabilitation